ReviewFrontiers in immunology2020

Anti-inflammatory and Neuroprotective Agents in Clinical Trials for CNS Disease and Injury: Where Do We Go From Here?

Khalil Mallah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.